MEDIA CENTER

Titanium Media | Frost & Sullivan: China has become the world's largest consumer and importer of cherries, but per capita consumption remains low
In recent years, among the many seasonal products, drifting across half the globe 20,000 Kilometers of Chilean cherries are considered top-notch, successfully occupying the Chinese dining table C Bit. What is the difference between cherries and plums? What is the market size of cherries? How much ro
Explore more
Blue Whale Finance | Frost & Sullivan executive: The healthcare industry will emerge from the winter slump, vaccines are expected to become a potential track sector, and digital transformation will bring new growth drivers to enterprises
How do you view the impact of the three years of the pandemic on the industry? Will sectors such as nucleic acid testing, vaccines, and COVID-19 drugs gradually withdraw from the historical stage? Can the profitability of related pharmaceutical companies continue? How do you view 'the past 2022 Is t
Explore more
Financial Wellness | Frost & Sullivan: It is expected that more healthcare companies will choose to issue GDRs on the Hong Kong Stock Exchange in 2023
How do you view Chinese pharmaceutical companies? 2022 Overall situation of overseas listings in the year, 2023 Will there be new changes in the coming year? Currently, there are multiple financing channels available overseas, such as Hong Kong and US stocks, Singapore, etc. What are their respectiv
Explore more
Securities Daily | Frost & Sullivan: Policy guidance on the use of underutilized land for photovoltaic projects is conducive to improving the economic viability of these projects
1 month 4 On the same day, Wang Guanghua, Minister of Natural Resources, said in an interview that the Ministry will study and introduce relevant policies to guide large-scale photovoltaic power generation projects to use unused land such as deserts, wastelands, and beaches for construction, promote
Explore more
China Business Times | Frost & Sullivan: Innovative pharmaceutical companies need to possess underlying independent innovation capabilities and commercialization execution abilities to break through
According to incomplete statistics, as of 2022 year 12 month 15 Today, this year the National Medical Products Administration of China NMPA The number of new drugs approved has exceeded 50 Among them, most are small molecule drugs, as well as more than a dozen biologics ADC New molecular therapies.
Explore more
Observer Network | Frost & Sullivan executive: With the full and smooth implementation of the registration-based system reform in the future, it is expected that the A-share market will continue to lead global capital markets
2022 year, A share IPO listing Both in terms of volume and financing amount, it far exceeds European and American markets. Shanghai Stock Exchange, Shenzhen Stock Exchange IPO listing The financing amount ranks first and second globally. Meanwhile, the US market IPO listing The amount raised decreas
Explore more
Caixin Business News | Frost & Sullivan: It is expected that the head-starting effect in the CXO market will continue in the future
As the 'water seller', the pharmaceutical outsourcing industry (hereinafter referred to as CXO The industry has always been highly regarded by the industry for its 'stable yields regardless of droughts or floods', with a high degree of prosperity. CXO The industry has always been a "regular customer
Explore more
Securities Daily | Frost & Sullivan: Overall price cuts in device centralized procurement have slowed down, and pricing has tended towards rationality and science
2022 What are the characteristics of the medical device centralized procurement in [year]? Is the trend towards no exclusion zones in centralized procurement more evident? In the future, which products will be included in the scope of centralized procurement? After the expiration of the coronary ste
Explore more
Financial Programs Center of China Media Group | Frost & Sullivan: Under the trend of increasing volume and stable prices, the wind power industry will enter a prosperous cycle
As of 2022 year 10 At the end of the month, the publicly tendered capacity for wind turbine equipment nationwide reached 73.3 GW Year-on-year growth 72.5% The bidding scale has far exceeded that of the whole year last year. 2023 Is the wind industry entering a prosperous cycle in 2024? 2023 How can
Explore more
Titanium Media | Frost & Sullivan executive: With the implementation of the 'New Ten Measures', macroeconomic development in 2023 will see relatively rapid growth
12 month 15 day after tomorrow 16 On the day, the Central Economic Work Conference was held in Beijing, during which it was repeatedly proposed to vigorously boost market confidence. 2023 What measures are expected to boost market confidence in the coming year? The meeting identified 'expanding dome
Explore more
